Advertisement

Specialty News

July 14, 2016
July 14, 2016
NIH has awarded approximately $30 million in annual funding over the next 5 years to six research collaborations working to advance basic medical...
NIH has awarded approximately $30 million in annual funding over the next 5 years to six research collaborations working to advance basic medical science toward an HIV cure. The awards are a part of President Barack Obama's pledge to invest in HIV cure research.
MORE
July 01, 2016
July 12, 2016
Tumor lysis syndrome (TLS), a potential complication of cancer treatment, occurs when malignant cells quickly lyse, or break open, and the internal...
Tumor lysis syndrome (TLS), a potential complication of cancer treatment, occurs when malignant cells quickly lyse, or break open, and the internal contents of the cell spill out into the bloodstream, causing metabolic abnormalities. Most often occurring 48–72 hours after the initiation of cancer treatment for hematologic malignancies, TLS may present before cancer therapy and occur with other tumor types, such as breast cancer, small cell lung cancer, and neuroblastoma.1-3
MORE
July 01, 2016
July 12, 2016
Navigating Medicare Part D drug coverage and patient liability can be confusing at best. What happens when a patient using the Part D benefit is...
Navigating Medicare Part D drug coverage and patient liability can be confusing at best. What happens when a patient using the Part D benefit is taking an expensive “specialty” medication? What is the patient’s financial obligation, and why?
MORE
May 20, 2016
May 20, 2016
*
MORE
April 13, 2016
April 13, 2016
**
MORE
April 13, 2016
April 13, 2016
**
MORE
April 13, 2016
April 13, 2016
**
MORE
April 13, 2016
April 13, 2016
**
MORE

Pages